Jasmin Röder

711 total citations
8 papers, 443 citations indexed

About

Jasmin Röder is a scholar working on Oncology, Immunology and Neurology. According to data from OpenAlex, Jasmin Röder has authored 8 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 8 papers in Immunology and 1 paper in Neurology. Recurrent topics in Jasmin Röder's work include Immune Cell Function and Interaction (8 papers), CAR-T cell therapy research (8 papers) and Immunotherapy and Immune Responses (3 papers). Jasmin Röder is often cited by papers focused on Immune Cell Function and Interaction (8 papers), CAR-T cell therapy research (8 papers) and Immunotherapy and Immune Responses (3 papers). Jasmin Röder collaborates with scholars based in Germany, United Kingdom and United States. Jasmin Röder's co-authors include Winfried S. Wels, Congcong Zhang, Mohammed H. Mosa, Tahmineh Darvishi, Henner F. Farin, Birgitta E. Michels, Theresa Schnalzger, Pranav Oberoi, Anja Waldmann and Malena Bodden and has published in prestigious journals such as The EMBO Journal, International Journal of Cancer and Molecular Therapy.

In The Last Decade

Jasmin Röder

8 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jasmin Röder Germany	6	370	216	125	81	53	8	443
Simiao Lin China	8	364 1.0×	208 1.0×	115 0.9×	119 1.5×	20 0.4×	9	465
Daniel Michaud United States	7	384 1.0×	313 1.4×	85 0.7×	117 1.4×	47 0.9×	11	527
Tania Rodríguez-Cruz United States	10	300 0.8×	189 0.9×	74 0.6×	136 1.7×	30 0.6×	14	397
Sanaz Taromi Germany	9	305 0.8×	139 0.6×	77 0.6×	156 1.9×	34 0.6×	13	422
Manon Pillai United Kingdom	7	359 1.0×	135 0.6×	137 1.1×	93 1.1×	17 0.3×	24	392
Alexander Biederstädt Germany	5	375 1.0×	402 1.9×	81 0.6×	155 1.9×	39 0.7×	9	604
Daijing Yuan China	7	314 0.8×	149 0.7×	78 0.6×	114 1.4×	14 0.3×	10	402
Annelisa M. Cornel Netherlands	9	245 0.7×	229 1.1×	27 0.2×	164 2.0×	52 1.0×	16	439
Theresa Schnalzger Germany	5	235 0.6×	85 0.4×	109 0.9×	75 0.9×	54 1.0×	6	302
Jiage Ding China	11	300 0.8×	227 1.1×	60 0.5×	128 1.6×	28 0.5×	18	414

Countries citing papers authored by Jasmin Röder

Since Specialization

Citations

This map shows the geographic impact of Jasmin Röder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jasmin Röder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jasmin Röder more than expected).

Fields of papers citing papers by Jasmin Röder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jasmin Röder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jasmin Röder. The network helps show where Jasmin Röder may publish in the future.

Co-authorship network of co-authors of Jasmin Röder

This figure shows the co-authorship network connecting the top 25 collaborators of Jasmin Röder. A scholar is included among the top collaborators of Jasmin Röder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jasmin Röder. Jasmin Röder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Röder, Jasmin, Tijna Alekseeva, Congcong Zhang, et al.. (2025). ErbB2/HER2-targeted CAR-NK cells eliminate breast cancer cells in an organoid model that recapitulates tumor progression. Molecular Therapy. 33(8). 3559–3575. 2 indexed citations

Röder, Jasmin, et al.. (2024). Dual Targeting of Glioblastoma Cells with Bispecific Killer Cell Engagers Directed to EGFR and ErbB2 (HER2) Facilitates Effective Elimination by NKG2D-CAR-Engineered NK Cells. Cells. 13(3). 246–246. 13 indexed citations

Zhang, Congcong, Pranav Oberoi, Malena Bodden, et al.. (2023). Multivalent adaptor proteins specifically target NK cells carrying a universal chimeric antigen receptor to ErbB2 (HER2)-expressing cancers. Cancer Immunology Immunotherapy. 72(9). 2905–2918. 5 indexed citations

Bodden, Malena, et al.. (2023). Co-Expression of an IL-15 Superagonist Facilitates Self-Enrichment of GD2-Targeted CAR-NK Cells and Mediates Potent Cell Killing in the Absence of IL-2. Cancers. 15(17). 4310–4310. 5 indexed citations

Straßheimer, F, Jasmin Röder, Tijna Alekseeva, et al.. (2022). AAV-mediated gene transfer of a checkpoint inhibitor in combination with HER2-targeted CAR-NK cells as experimental therapy for glioblastoma. OncoImmunology. 11(1). 2127508–2127508. 36 indexed citations

Zhang, Congcong, Jasmin Röder, Anne Scherer, et al.. (2021). Bispecific antibody-mediated redirection of NKG2D-CAR natural killer cells facilitates dual targeting and enhances antitumor activity. Journal for ImmunoTherapy of Cancer. 9(10). e002980–e002980. 48 indexed citations

Schnalzger, Theresa, Congcong Zhang, Mohammed H. Mosa, et al.. (2019). 3D model for CAR ‐mediated cytotoxicity using patient‐derived colorectal cancer organoids. The EMBO Journal. 38(12). 263 indexed citations

Oelsner, Sarah, Anja Waldmann, Jasmin Röder, et al.. (2019). Genetically engineered CAR NK cells display selective cytotoxicity against FLT3‐positive B‐ALL and inhibit in vivo leukemia growth. International Journal of Cancer. 145(7). 1935–1945. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact